173 related articles for article (PubMed ID: 35116365)
1. Prognostic impact of sarcopenia on immune-related adverse events in malignancies received immune checkpoint inhibitors: a systematic review and meta-analysis.
Li S; Wang T; Lai W; Zhang M; Cheng B; Wang S; Tong G
Transl Cancer Res; 2021 Dec; 10(12):5150-5158. PubMed ID: 35116365
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Impact of Sarcopenia on Clinical Outcomes in Malignancies Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.
Li S; Wang T; Tong G; Li X; You D; Cong M
Front Oncol; 2021; 11():726257. PubMed ID: 34513704
[TBL] [Abstract][Full Text] [Related]
3. Sarcopenia and the risk of adverse events in patients treated with immune checkpoint inhibitors: a systematic review.
Guzman-Prado Y; Ben Shimol J; Samson O
Cancer Immunol Immunother; 2021 Oct; 70(10):2771-2780. PubMed ID: 33625531
[TBL] [Abstract][Full Text] [Related]
4. Serological response and immune-related adverse events following COVID-19 vaccination in cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis.
Wang Y; Chen D; Pan Y; Li H; Zhao W; Lu T; Kong W; Ding M; Wang X; Zhang G
Rev Med Virol; 2024 Jan; 34(1):e2495. PubMed ID: 38017632
[TBL] [Abstract][Full Text] [Related]
5. The association between immune-related adverse events and the prognosis of solid cancer patients treated with immunotherapy: a systematic review and meta-analysis.
Xu H; Xu X; Ge W; Lei J; Cao D
Ther Adv Med Oncol; 2020; 12():1758835920980546. PubMed ID: 33425028
[TBL] [Abstract][Full Text] [Related]
6. Immune-related adverse events associated with immune checkpoint inhibitors for advanced gastric and gastroesophageal junction cancer: A meta-analysis.
Pei WG; Chen WZ; Wu YK; Tan SX; Jie ZG
World J Gastrointest Oncol; 2023 Feb; 15(2):352-367. PubMed ID: 36908315
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for adverse events induced by immune checkpoint inhibitors in patients with non-small-cell lung cancer: a systematic review and meta-analysis.
Suazo-Zepeda E; Bokern M; Vinke PC; Hiltermann TJN; de Bock GH; Sidorenkov G
Cancer Immunol Immunother; 2021 Nov; 70(11):3069-3080. PubMed ID: 34195862
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of immune-related adverse events of immune checkpoint inhibitor therapy in cancer patients.
Song P; Zhang D; Cui X; Zhang L
Thorac Cancer; 2020 Sep; 11(9):2406-2430. PubMed ID: 32643323
[TBL] [Abstract][Full Text] [Related]
9. Association of Immune Related Adverse Events With Efficacy of Immune Checkpoint Inhibitors and Overall Survival in Cancers: A Systemic Review and Meta-analysis.
Fan Y; Xie W; Huang H; Wang Y; Li G; Geng Y; Hao Y; Zhang Z
Front Oncol; 2021; 11():633032. PubMed ID: 33912454
[TBL] [Abstract][Full Text] [Related]
10. Adverse events associated with immune checkpoint inhibitors in patients with breast cancer: A systematic review and meta-analysis.
Balibegloo M; Nejadghaderi SA; Sadeghalvad M; Soleymanitabar A; Salehi Nezamabadi S; Saghazadeh A; Rezaei N
Int Immunopharmacol; 2021 Jul; 96():107796. PubMed ID: 34162158
[TBL] [Abstract][Full Text] [Related]
11. Immune-related adverse events: promising predictors for efficacy of immune checkpoint inhibitors.
Zhong L; Wu Q; Chen F; Liu J; Xie X
Cancer Immunol Immunother; 2021 Sep; 70(9):2559-2576. PubMed ID: 33576872
[TBL] [Abstract][Full Text] [Related]
12. Association between immune-related side effects and efficacy and benefit of immune checkpoint inhibitors - A systematic review and meta-analysis.
Hussaini S; Chehade R; Boldt RG; Raphael J; Blanchette P; Maleki Vareki S; Fernandes R
Cancer Treat Rev; 2021 Jan; 92():102134. PubMed ID: 33302134
[TBL] [Abstract][Full Text] [Related]
13. Immune-Related Adverse Events as Clinical Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.
Martini DJ; Goyal S; Liu Y; Evans ST; Olsen TA; Case K; Magod BL; Brown JT; Yantorni L; Russler GA; Caulfield S; Goldman JM; Nazha B; Harris WB; Kissick HT; Master VA; Kucuk O; Carthon BC; Bilen MA
Oncologist; 2021 Oct; 26(10):e1742-e1750. PubMed ID: 34156726
[TBL] [Abstract][Full Text] [Related]
14. Preexisting autoimmune disease is a risk factor for immune-related adverse events: a meta-analysis.
Yamaguchi A; Saito Y; Okamoto K; Narumi K; Furugen A; Takekuma Y; Sugawara M; Kobayashi M
Support Care Cancer; 2021 Dec; 29(12):7747-7753. PubMed ID: 34164739
[TBL] [Abstract][Full Text] [Related]
15. A Network Comparison on Safety Profiling of Immune Checkpoint Inhibitors in Advanced Lung Cancer.
Yan YD; Cui JJ; Fu J; Su YJ; Chen XY; Gu ZC; Lin HW
Front Immunol; 2021; 12():760737. PubMed ID: 34925331
[TBL] [Abstract][Full Text] [Related]
16. Safety and Efficacy of the Rechallenge of Immune Checkpoint Inhibitors After Immune-Related Adverse Events in Patients With Cancer: A Systemic Review and Meta-Analysis.
Zhao Q; Zhang J; Xu L; Yang H; Liang N; Zhang L; Zhang F; Zhang X
Front Immunol; 2021; 12():730320. PubMed ID: 34646270
[TBL] [Abstract][Full Text] [Related]
17. Immune-Related Adverse Events Predict the Efficacy of Immune Checkpoint Inhibitors in Lung Cancer Patients: A Meta-Analysis.
Wang D; Chen C; Gu Y; Lu W; Zhan P; Liu H; Lv T; Song Y; Zhang F
Front Oncol; 2021; 11():631949. PubMed ID: 33732650
[TBL] [Abstract][Full Text] [Related]
18. Adverse events of neoadjuvant combination immunotherapy for resectable cancer patients: a systematic review and meta-analysis.
Feng Y; Guo K; Jin H; Jiang J; Wang M; Lin S
Front Immunol; 2023; 14():1269067. PubMed ID: 38250059
[TBL] [Abstract][Full Text] [Related]
19. Organ-Specific Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitor Monotherapy Versus Combination Therapy in Cancer: A Meta-Analysis of Randomized Controlled Trials.
Da L; Teng Y; Wang N; Zaguirre K; Liu Y; Qi Y; Song F
Front Pharmacol; 2019; 10():1671. PubMed ID: 32082164
[TBL] [Abstract][Full Text] [Related]
20. Cardiac adverse events of immune checkpoint inhibitors in oncology patients: A systematic review and meta-analysis.
Nso N; Antwi-Amoabeng D; Beutler BD; Ulanja MB; Ghuman J; Hanfy A; Nimo-Boampong J; Atanga S; Doshi R; Enoru S; Gullapalli N
World J Cardiol; 2020 Nov; 12(11):584-598. PubMed ID: 33312443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]